ABOUT HEALTHCARE NEWS

Britain’s drug regulator accepted the Alzheimer’s drug Kisunla on Wednesday, but the government received’t be paying for it following an impartial watchdog agency stated the cure isn’t well worth the Expense to taxpayersFowl flu constraints lead to heartache for 4-H Youngsters struggling to showcase livestock at fairs across US [deltaMinute